Metaxalone
- Product NDC
- 72789-028
- 11-digit product format
- 727890028
- Labeler code
- 72789
- Product ID
- 72789-028_2d58ab65-a0e3-e2a2-e063-6294a90a0e4a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Metaxalone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA207466
- Marketing category
- ANDA
- Marketing start
- 2017-08-31
- Substance
- METAXALONE
- Active strength
- 800 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
openFDA Listing Details
- Product ID
- 72789-028_2d58ab65-a0e3-e2a2-e063-6294a90a0e4a
- Product type
- HUMAN PRESCRIPTION DRUG
- Finished product
- Yes
- Brand name base
- Metaxalone
- Generic name
- Metaxalone
- Dosage form
- TABLET
- Route
- ORAL
- Marketing start
- 2017-08-31
- Marketing category
- ANDA
- Application number
- ANDA207466
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]
- Listing expiration
- 2026-12-31
openFDA Active Ingredients
| Ingredient | Strength |
|---|
| METAXALONE | 800 mg/1 |
openFDA Harmonized Identifiers
| Field | Values |
|---|
| Unii | 1NMA9J598Y |
| Rxcui | 351254 |
| Spl Set Id | edc6ba8d-2d45-4833-8dc7-e2d4e5d72856 |
| Manufacturer Name | PD-Rx Pharmaceuticals, Inc. |
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 1NMA9J598Y | METAXALONE | 1665-48-1 | METAXALONE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72789-028-15 | 72789002815 | 15 TABLET in 1 BOTTLE, PLASTIC (72789-028-15) | 15 tablet | 2019-11-19 | 0000-00-00 | No | No | Current |
| 72789-028-30 | 72789002830 | 30 TABLET in 1 BOTTLE, PLASTIC (72789-028-30) | 30 tablet | 2019-11-11 | 0000-00-00 | No | No | Current |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Metaxalone | PD-Rx Pharmaceuticals, Inc. | 2025-02-04 | HUMAN PRESCRIPTION DRUG LABEL | 13 |